Our data suggest that the reduction of NFκB activity is a critical consequence of USP14 inhibition and that therapeutic inhibition of USP14 in combination with radiation treatment enhances survival in HNSCC xenograft in vivo in a host TNF-dependent manner. This evidence concerns the gene USP14 and head and neck squamous cell carcinoma.